Last reviewed · How we verify
Amlodipine-FA tablet,low dose group
Amlodipine-FA is a calcium channel blocker that works by relaxing blood vessels and reducing blood pressure.
Amlodipine-FA is a calcium channel blocker that works by relaxing blood vessels and reducing blood pressure. Used for Hypertension, Angina pectoris.
At a glance
| Generic name | Amlodipine-FA tablet,low dose group |
|---|---|
| Also known as | low dose |
| Sponsor | Shenzhen Ausa Pharmed Co.,Ltd |
| Drug class | Calcium channel blocker |
| Target | L-type calcium channels |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 2 |
Mechanism of action
Amlodipine-FA, a dihydropyridine calcium channel blocker, inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle, resulting in vasodilation and reduced blood pressure. This action is thought to be mediated through the inhibition of L-type calcium channels.
Approved indications
- Hypertension
- Angina pectoris
Common side effects
- Edema
- Dizziness
- Headache
- Fatigue
- Nausea
Key clinical trials
- Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine (PHASE2, PHASE3)
- Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: